Without Your DEA Registration, There Is No Pharmacy.
Dhairya Jani is a former DEA Diversion Enforcement Counsel representing independent pharmacies, pharmacy chains, and compounding pharmacies in DEA administrative enforcement proceedings and civil penalty matters.
When the DEA targets a pharmacy, it is not just a regulatory matter. It is a direct threat to the business itself. Jani Law PLLC represents pharmacies from the first investigative contact through the Administrative Law Judge hearing and final agency order.
How the DEA Builds Its Case Against a Pharmacy
DEA enforcement against pharmacies rests on two regulations working in tandem.
- Under 21 C.F.R. § 1306.04(a), a prescription is valid only if issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. The regulation expressly places a corresponding responsibility on the pharmacist who fills the prescription to ensure its validity.
- Under 21 C.F.R. § 1306.06, a pharmacist may dispense controlled substances only pursuant to a valid prescription, while acting in the usual course of professional practice.
The DEA’s theory in most pharmacy enforcement cases is that the pharmacy dispensed prescriptions that were not valid because:
- They lacked a legitimate medical purpose
- The pharmacist identified red flags and filled anyway
- The pharmacist failed to identify red flags that should have been caught
The corresponding responsibility doctrine, derived from 21 C.F.R. § 1306.04(a), has historically been the DEA’s central enforcement tool in pharmacy cases. Under that framework, the adequacy of a pharmacist’s red flag documentation has been the terrain on which most pharmacy enforcement cases are won or lost.
A Significant Development: Neumann’s Pharmacy L.L.C. v. DEA (5th Cir. Feb. 13, 2026)
In Neumann’s Pharmacy, L.L.C. v. Drug Enf’t Admin., 2026 WL 411942 (5th Cir. Feb. 13, 2026), the Fifth Circuit unanimously vacated a DEA deregistration order on two grounds.
- First, the court held that § 1306.04(a) requires the DEA to prove the pharmacist filled an invalid prescription knowingly, rejecting the Agency’s longstanding objective standard that a pharmacist “knows or has reason to know.”
- Second, the court held that acting outside the usual course of professional practice means something closer to abandoning the pharmacist’s role entirely, not merely falling short of state-law care standards.
Neumann’s is binding in the Fifth Circuit and available as persuasive authority in other circuits. Its reasoning directly affects how pharmacy enforcement cases are built and challenged.
What the DEA Examines in a Pharmacy
DEA investigators know exactly what to look for. The following areas are the most common sources of enforcement exposure:
Schedule II Ordering — DEA Form 222 / CSOS
Every acquisition or transfer of a Schedule II controlled substance must be executed on a DEA Form 222 or its electronic equivalent under 21 C.F.R. § 1305.03. Errors, missing forms, and mismatches between forms and actual receipts are among the most common pharmacy enforcement findings. All records must be retained for two years and made available for DEA inspection on demand.
Biennial Physical Inventory
A complete physical inventory of all Schedules II through V controlled substances is required every two years under 21 C.F.R. § 1304.11. It must be conducted on an exact date, signed by the responsible pharmacist, and retained. Absent, unsigned, or undated inventories are recurring enforcement targets.
Dispensing Records
Every dispensing event must generate a complete record under 21 C.F.R. § 1304.22: patient name and address, date dispensed, drug name and strength, quantity, prescriber information, and pharmacist identifier. Incomplete or missing dispensing records are a direct regulatory violation and a common basis for enforcement action.
Powers of Attorney for Schedule II Ordering
Only personnel holding a valid DEA Power of Attorney under 21 C.F.R. § 1305.05 may execute Schedule II orders. Outdated, unexecuted, or missing powers of attorney for personnel who ordered Schedule II substances create recordkeeping and chain-of-custody exposure.
Theft and Significant Loss Reporting
Significant theft or loss of controlled substances must be reported to the DEA Field Division Office within one day of discovery under 21 C.F.R. § 1301.76. Failure to timely report is itself a violation, independent of the underlying loss.
Physical Security and Operational Controls
Schedule II controlled substances must be stored in a securely locked, substantially constructed cabinet or safe meeting DEA standards under 21 C.F.R. § 1301.72. Investigators examine access logs, key and combination controls, alarm systems, and employee termination procedures. The gap between written security policy and actual operational execution is a recurring enforcement exposure point.
Protect Your Pharmacy and Your Livelihood: Contact Jani Law PLLC
If you own or manage a pharmacy and are facing DEA enforcement, Jani Law PLLC is on your side. As a former DEA Diversion Enforcement Counsel, Dhairya Jani brings firsthand experience of how these cases are built and where they can be challenged to defend your business and livelihood. To request a free, confidential consultation, contact our law firm today.